Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)
South Korea · Delayed Price · Currency is KRW 7,730.00
+210.00 (2.79%)
At close: Apr 24, 2026
KOSDAQ:318160 Revenue
In the year 2025, Cell Bio Human Tech Co.,Ltd had annual revenue of 51.07B KRW with 79.69% growth. Cell Bio Human Tech Co.,Ltd had revenue of 14.25B in the quarter ending December 31, 2025, with 72.72% growth.
Revenue
51.07B
Revenue Growth
+79.69%
P/S Ratio
1.27
Revenue / Employee
680.88M
Employees
75
Market Cap
64.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 51.07B | 22.65B | 79.69% |
| Dec 31, 2024 | 28.42B | 1.09B | 4.01% |
| Dec 31, 2023 | 27.32B | -220.33M | -0.80% |
| Dec 31, 2022 | 27.54B | -7.62B | -21.66% |
| Dec 31, 2021 | 35.16B | 6.57B | 22.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inzi Display Co.,Ltd | 721.81B |
| Guyoung Technology | 426.18B |
| Cherrybro co.,Ltd | 405.44B |
| Dongil Metal | 91.71B |
| GGUMBI | 86.39B |
| WINPAC | 75.55B |
| Milae Bioresources | 67.55B |
| IDP Corp. | 49.08B |